Prodisc C Vivo is one of the most used total disc replacement implants in the world, and it was deuted in the U.S. on Sept. 7, according to a news release. Since its U.S. debut, more than 70 surgeons have ben trained to use the device, and more than 30 new surgeons are using it.
The device uses the Prodisc Core technology, which has been used in more than 225,000 cases worldwide. Centinel Spine’s cervical total disc replacement portfolio has four devices that are FDA approved for 1-level indications.
“The prodisc C Vivo system incorporates the simplicity of a keel-less disc replacement implant without sacrificing stability, an issue seen in many other implants,” Adam Bruggeman, MD, said in the release. “This is the best of both worlds in disc replacement and will rapidly be adopted by surgeons who embrace motion preservation.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
